Autres langues Caplin Point Laboratories Limited

Actions

CAPLIPOINT

INE475E01026

Produits pharmaceutiques

Temps Différé Bombay S.E. Autres places de cotation 10:50:13 18/06/2026			Varia. 5j.	Varia. 1 janv.
2 360,00 ^INR	+1,15%		+1,25%	+28,18%

15/05	Transcript : Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
14/05	Caplin Point Laboratories Limited publie ses résultats pour le quatrième trimestre et l'exercice clos le 31 mars 2026	CI

Autres langues

14/05	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
14/05	Caplin Point Laboratories' Consolidated Profit Rises in Fiscal Q4; Shares Jump 10%
14/05	Caplin Point Laboratories March-quarter consol net profit 1.7 bln rupees
05/05	Caplin Point Laboratories Unit Gets US FDA's Final Nod for Calcium Gluconate Injection
13/03	Caplin Point Laboratories Unit Gets US FDA's Nod for Potassium Phosphates Injection
13/03	Caplin Point Laboratories unit receives final USFDA approval for ANDA potassium phosphates injection
03/03	Caplin Point Laboratories Limited Announces Cessation of C K Gariyali as Independent Director, with Effect from the Close of Business Hours on March 03, 2026
24/02	Indian Markets Slide on Tuesday as Global Trade Concerns Weigh
24/02	Caplin Point Laboratories Arm Gets US FDA's Final Approval for Sodium Phosphates Injection
24/02	Caplin Point Laboratories says unit receives USFDA approval for sodium phosphates injection
05/02	Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
05/02	Caplin Point Laboratories Dec-quarter consol net profit 1.64 billion rupees
03/02	Caplin Point Laboratories Limited Announces Changes to Its Board
27/01	Caplin Point Laboratories unit receives USFDA approval for methylprednisolone acetate
09/12	Caplin Point Laboratories Gets US FDA Nod for Linezolid Injection
09/12	Caplin Point Laboratories unit gets USFDA final approval for Linezolid Injection, Infusion bags
08/12	Caplin Point Laboratories unit receives final US FDA approval for its ANDA Acetaminophen Injection
05/11	Caplin Point Laboratories appoints Ashok Partheeban as vice-chairman
05/11	Caplin Point Laboratories Limited Announces Executive Changes , Effective November 5, 2025
05/11	Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
05/11	Caplin Point Laboratories Sept-quarter consol net profit 1.54 billion rupees
23/10/25	Caplin Point Laboratories says Caplin Steriles receives USFDA approval for Nicardipine Injection
03/09/25	Caplin Steriles Limited Receives Final Approval from the United States Food and Drug Administration for its Abbreviated New Drug Application Milrinone Lactate in 5% Dextrose Injection
07/08/25	Caplin Point Laboratories' Consolidated Profit Rises in Fiscal Q1; Shares Up 3%
07/08/25	Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025